Top 5 DRAP-Approved Clinical Trial Sites in Pakistan
1. PMC Clinical Trial Unit (CTU) – Islamabad
The PMC Clinical Trial Unit (CTU) is one of the most reputable and DRAP-approved clinical research organizations in Pakistan. Located in Islamabad, CTU operates under Pakistan Medical Commission (PMC) and has established itself as a center of excellence for clinical research, patient safety, and data integrity.
The PMC Clinical Trial Unit offers full-spectrum services from Phase I to Phase IV clinical trials, focusing on drug safety, bioequivalence, and innovative therapeutic testing. The unit is equipped with state-of-the-art research facilities, experienced investigators, GCP-trained staff, and a strong ethics committee to ensure compliance with DRAP (Drug Regulatory Authority of Pakistan) and ICH-GCP guidelines.
Key Strengths:
- Certified by DRAP and compliant with ICH-GCP protocols
- In-house ethics review board
- 24/7 patient monitoring and laboratory services
- Transparent reporting and quality data management
- Collaborations with international research sponsors
PMC CTU is also recognized for training clinical researchers and supporting academic research through professional mentorship and data analysis support. It plays a key role in bridging the gap between academic medicine and clinical application in Pakistan.
2. Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC) – Lahore
SKMCH&RC is a pioneer in cancer research and clinical trials in Pakistan. The hospital’s research wing conducts oncology-based clinical trials in collaboration with global pharmaceutical companies and academic institutions.
Highlights:
- DRAP-registered research site
- Focus on Phase II and Phase III cancer drug trials
- Ethical committee recognized by DRAP
- Advanced data management and patient safety protocols
The hospital’s commitment to evidence-based cancer treatment has made it one of the most trusted names in clinical trials within South Asia.
3. Aga Khan University Hospital (AKUH) – Karachi
Aga Khan University Hospital stands as a leading academic medical research institution in Pakistan. It holds DRAP accreditation for conducting national and international clinical trials across multiple therapeutic areas, including infectious diseases, cardiology, and neurology.
Key Research Facilities:
- Centralized data management system
- Dedicated Clinical Trials Unit (CTU)
- Collaboration with NIH, WHO, and international sponsors
- Certified Clinical Research Associates (CRAs) and investigators
AKUH ensures the highest standards of ethical governance, patient safety, and global compliance in every research study it undertakes.
4. Jinnah Postgraduate Medical Centre (JPMC) – Karachi
JPMC is one of Pakistan’s largest public-sector teaching hospitals, known for its clinical excellence and research diversity. The center has a DRAP-approved Clinical Research Unit that facilitates government-sponsored and collaborative studies.
Features:
- Research conducted under public-private partnerships
- Focus on infectious disease, surgery, and pharmacology trials
- Onsite ethics and review committee
- Access to diverse patient populations
JPMC’s infrastructure and medical expertise enable large-scale multi-center clinical trials, contributing significantly to Pakistan’s research ecosystem.
5. Dow University of Health Sciences (DUHS) – Karachi
Dow University’s Clinical Research Unit has gained DRAP approval for conducting clinical, pre-clinical, and bioequivalence studies. It has established a reputation for academic collaboration and pharmaceutical testing across Pakistan.
Highlights:
- DRAP-certified laboratory and trial facilities
- Focus on pharmacological and vaccine trials
- Training programs for clinical researchers
- Ethical oversight and quality assurance committees
DUHS collaborates with national health agencies and international partners to develop safe and effective therapeutic interventions for the Pakistani population.
🌐 Why DRAP Approval Matters
The Drug Regulatory Authority of Pakistan (DRAP) plays a crucial role in maintaining ethical standards, patient safety, and data reliability in all clinical trials conducted across the country. A DRAP-approved research site ensures:
- Compliance with global Good Clinical Practice (GCP) standards
- Transparency and traceability in data collection
- Accountability and ethical patient recruitment
- Reliability for international collaboration
By working with DRAP-approved sites like the PMC Clinical Trial Unit, pharmaceutical companies and research sponsors gain confidence in both scientific validity and ethical compliance.
🧠 The Future of Clinical Research in Pakistan
Pakistan’s clinical research sector is rapidly expanding, thanks to DRAP’s continuous reforms and the dedication of leading institutions like PMC CTU, AKUH, and SKMCH&RC. With advancements in digital data collection, electronic health records, and AI-based monitoring, the future holds vast potential for clinical research innovation.
The PMC Clinical Trial Unit continues to lead the transformation, supporting global health studies, vaccine development, and patient-centric trials that align with both national and international healthcare objectives.
🧾 Conclusion
Clinical research in Pakistan is thriving under the guidance of DRAP-approved institutions. Among them, the PMC Clinical Trial Unit (CTU) stands out as a benchmark of clinical excellence, providing ethical, accurate, and impactful research that contributes to medical advancement and patient welfare.
For more details about ongoing trials, services, and collaborations, visit the official PMC Clinical Trial Unit website here:
👉 https://ctu.pmcpk.com/
